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Dear Editors,
We have read the article ‘‘Increased P-wave dispersion
(PWD) in patients with newly diagnosed lichen planus
(LP)’’ by Sahin et al. (1). These researchers aimed to
investigate PWD in patients with LP, and they concluded
that PWD increased in the surface electrocardiographic
measurements of LP patients. This result may be important
for the early detection of subclinical cardiac involvement.
This study provides important information on this clinically
relevant condition. The ready availability of this parameter
at no additional cost may encourage its wider use in clinical
practice in the future. The authors should be commended
for their contribution.
LP is a chronic inflammatory autoimmune mucocuta-
neous disease. Although its pathogenesis is not fully
understood, it is recognized as a chronic disease that is
almost certainly immunologically mediated. Several studies
have shown that prolonged PWD has predictive value for
the development of atrial fibrillation (AF) in patients with or
without apparent heart disease. In addition to predicting
AF, prolonged PWD has also been observed in various
clinical settings. Cross-sectional studies have demonstrated
that subjects with hypertension, obesity, diabetes, and
coronary artery disease have prolonged PWD compared
with controls. Apart from the above-mentioned diseases,
some conditions, such as seasonal variation, alcohol intake,
and caffeine ingestion, have been demonstrated to affect
PWD.
Hepatic steatosis is associated with metabolic and
hemodynamic abnormalities induced by insulin resistance
and severe inflammation. Increased PWD may indicate a
risk of atrial arrhythmia in patients with inflammation-
based hepatic steatosis (2). Prolonged PWD has also been
observed in patients with stable asthma (3). Furthermore,
PWD is independently associated with renal function. In a
previous study, researchers showed that PWD is a novel
parameter that may accurately predict AF and was
increased in renal failure patients (4).
Prolonged atrial electromechanical coupling time and
impaired mechanical atrial functions may be related to the
increased incidence of arrhythmias. Thyroid hormone levels
may affect atrial electromechanical function. In a previous
study, researchers demonstrated prolonged PWD in
patients with thyroid disorders (5). Additionally, some
medications, such as propylthiouracil and methimazole,
were found to reduce the P wave duration and dispersion
(6). Furthermore, antihypertensive therapy, such as short-
term treatment with quinapril, irbesartan, atenolol, and
nebivolol, reduces the duration of PWD. This effect is
independent of blood pressure and heart rate changes.
Additionally, lipid-lowering therapy significantly reduced
PWD, a finding that may be important in the prevention of
AF in hyperlipidemic patients.
In conclusion, although prolonged PWD was observed in
the surface electrocardiographic measurements of LP
patients as presented in the current study, PWD may be
affected by various conditions and medications. Therefore,
further studies should evaluate prolonged PWD-related
conditions.
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